Warren, John B Dimmitt, Simon B Stampfer, Hans G
Published in
British journal of clinical pharmacology
An overview of clinical trials can reveal a class effect on mortality that is not apparent from individual trials. Most large trials of lipid pharmacotherapy are not powered to detect differences in mortality and instead assess efficacy with composite cardiovascular endpoints. We illustrate the importance of all-cause mortality data by comparing su...
Al-Sallami, Hesham Newall, Fiona Monagle, Paul Ignjatovic, Vera Cranswick, Noel Duffull, Stephen
Published in
British journal of clinical pharmacology
A PKPD model to describe the time course of the UFH effect was developed in a paediatric population. FFM was shown to describe drug disposition well. However, when applied to smaller UFH infusion doses, the model overpredicted target aPTT responses. This unsuccessful extrapolation may be attributed to a possible nonlinear relationship for heparin P...
Namour, Florence Galien, René Van Kaem, Tim Van der Aa, Annegret Vanhoutte, Frédéric Beetens, Johan Van't Klooster, Gerben
Published in
British journal of clinical pharmacology
Free fatty acids (FFA) can act as direct signalling molecules through activation of several membrane-bound G-protein coupled receptors. The FFA2 receptor (known as GPR43) is activated by short chain fatty acids (SCFA) such as acetate and has been shown to play a major role in SCFA-induced neutrophil activation and migration and to contribute in the...
Neves, Daniel V Lanchote, Vera L Moysés Neto, Miguel Cardeal da Costa, José A Vieira, Carolina P Coelho, Eduardo B
Published in
British journal of clinical pharmacology
Stage 3 and 4 CKD increases the plasma concentrations of both nebivolol enantiomers, while haemodialysis restores the pharmacokinetic parameters to values similar to those observed in the control group. No significant difference in heart rate variation induced by isometric exercise was observed between the investigated groups after the administrati...
Donati, Monia Conforti, Anita Lenti, Maria Carmela Capuano, Annalisa Bortolami, Oscar Motola, Domenico Moretti, Ugo Vannacci, Alfredo Rafaniello, Concetta Vaccheri, Alberto
...
Published in
British journal of clinical pharmacology
Drug-induced liver injury is one of the most serious adverse drug reactions and the most frequent reason for restriction of indications or withdrawal of drugs. Some nonsteroidal anti-inflammatory drugs (NSAIDs) were withdrawn from the market because of serious hepatotoxicity. We estimated the risk of acute and serious liver injury associated with t...
El Alili, Mohamed Vrijens, Bernard Demonceau, Jenny Evers, Silvia M Hiligsmann, Mickael
Published in
British journal of clinical pharmacology
Different methods are available for measuring medication adherence. In this paper, we conducted a scoping review to identify and summarize evidence of all studies comparing the Medication Event Monitoring System (MEMS) with alternative methods for measuring medication adherence. A literature search was performed using the open database www.iAdheren...
Karanges, Emily A Blanch, Bianca Buckley, Nicholas A Pearson, Sallie-Anne
Published in
British journal of clinical pharmacology
The aim of this paper is to investigate 25-year trends in community use of prescribed opioid analgesics in Australia, and to map these trends against major changes to opioid registration and subsidy. We obtained dispensing data from 1990 to 2014 from two sources: dispensing claims processed under Australia's national drug subsidy programme, the Pha...
Nath, Christa E Trotman, Judith Tiley, Campbell Presgrave, Peter Joshua, Douglas Kerridge, Ian Kwan, Yiu Lam Gurney, Howard McLachlan, Andrew J Earl, John W
...
Published in
British journal of clinical pharmacology
This large scale pharmacodynamic analysis of HDM demonstrates that high melphalan exposure is associated with improved survival, with an acceptable increase in transplant toxicity. These results suggest studies targeting a higher AUC are warranted in patients undergoing HDM and ASCT for myeloma.
Chen, Xia Zhao, Qian Hou, Yong Jiang, Ji Zhong, Wen Wang, Wenxiang Yao, Xuejing Li, Lin Fang, Jianmin Zhang, Fengchun
...
Published in
British journal of clinical pharmacology
The study results support further development of RCT-18 in RA patients and provide important information for future dose selection.
Bailey, Chantelle Peddie, David Wickham, Maeve E Badke, Katherin Small, Serena S Doyle-Waters, Mary M Balka, Ellen Hohl, Corinne M
Published in
British journal of clinical pharmacology
We found substantial variability in the data fields used to report ADEs, limiting the comparability of ADE data collected using different reporting systems, and undermining efforts to aggregate data across cohorts. The development of a common standardized data set that can be evaluated with regard to data quality, comparability and reporting rates ...